News

Filter

Current filters:

USAOphthalmics

151 to 160 of 96144 results

Luye Pharma to acquire majority stake in Beijing Jialin for $599 million

Luye Pharma to acquire majority stake in Beijing Jialin for $599 million

03-09-2014

Hong Kong-based Luye Pharma has entered into an agreement to purchase a 57.98% stake of Beijing Jialin…

Beijing Jialin PharmaceuticalCardio-vascularChinaLuye PharmaMergers & AcquisitionsPharmaceutical

Strong Ph IIb results with Dezima’s CETP inhibitor TA-8995 in dyslipidemia

Strong Ph IIb results with Dezima’s CETP inhibitor TA-8995 in dyslipidemia

03-09-2014

Privately-held Dutch biotech firm Dezima Pharma says it has received very positive results in its Phase…

BiotechnologyCardio-vascularDEZ-001Dezima PharmaMitsubishi TanabeResearchTA-8995

FDA accepts Actavis NDA for eluxadoline

FDA accepts Actavis NDA for eluxadoline

03-09-2014

Ireland-headquartered generic drug major Actavis says that the US Food and Drug Administration has accepted…

ActaviseluxadolineForest LaboratoriesFuriex PharmaceuticalsGastro-intestinalsPharmaceuticalRegulationUSA

FDA Breakthrough designation for ACADIA’s Nuplazid for Parkinson’s disease psychosis

FDA Breakthrough designation for ACADIA’s Nuplazid for Parkinson’s disease psychosis

03-09-2014

US biotech firm ACADIA Pharmaceuticals says that the US Food and Drug Administration has granted Breakthrough…

ACADIA PharmaceuticalsBiotechnologyNeurologicalNuplazidpimavanserinRegulationUSA

Bristol-Myers Squibb launches Daklinza in the UK for chronic hepatitis C

Bristol-Myers Squibb launches Daklinza in the UK for chronic hepatitis C

03-09-2014

US drug major Bristol-Myers Squibb has launched Daklinza (daclastavir) in the UK for chronic hepatitis…

AntiviralsBristol-Myers SquibbDaklinzaHepatitis CNephrology and HepatologyPharmaceuticalRegulationUK

151 to 160 of 96144 results

Back to top